OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension

Status:
Completed

Trial end date:
2014-10-30

Target enrollment:

Participant gender:

This is a clinical trial to test an experimental drug for the treatment of Eosinophilic Esophagitis (EoE)

Phase 2

Shire

Budesonide